van Meerbeeck JP - Search Results

1

BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer.

Rolfo C, Raez LE, Bronte G, Santos ES, Papadimitriou K, Buffoni L, van Meerbeeck JP, Russo A. Rolfo C, et al. Among authors: van meerbeeck jp. Expert Opin Investig Drugs. 2013 Aug;22(8):1081-8. doi: 10.1517/13543784.2013.812630. Epub 2013 Jun 22. Expert Opin Investig Drugs. 2013. PMID: 23790097 Review.

2

Disseminated lung cancer or extragonadal germ cell tumour?

Wouters E, Van Meerbeeck J, Dirix L, Janssen M, Van Marck E, Vermeire P, Van Oosterom A. Wouters E, et al. Eur Respir J. 1991 Jan;4(1):84-7. Eur Respir J. 1991. PMID: 1851105

3

Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer.

De Pauw R, van Meerbeeck JP. De Pauw R, et al. Among authors: van meerbeeck jp. Curr Opin Oncol. 2007 Mar;19(2):92-7. doi: 10.1097/CCO.0b013e328011bed9. Curr Opin Oncol. 2007. PMID: 17272979 Review.

4

What is the role for surgery in patients with stage III non-small cell lung cancer?

Vandenbroucke E, De Ryck F, Surmont V, van Meerbeeck JP. Vandenbroucke E, et al. Among authors: van meerbeeck jp. Curr Opin Pulm Med. 2009 Jul;15(4):295-302. doi: 10.1097/MCP.0b013e32832cbefc. Curr Opin Pulm Med. 2009. PMID: 19465855 Review.

5

Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.

De Craene S, Surmont V, van Meerbeeck JP. De Craene S, et al. Among authors: van meerbeeck jp. Curr Opin Oncol. 2010 Mar;22(2):102-11. doi: 10.1097/cco.0b013e328335c076. Curr Opin Oncol. 2010. PMID: 20180283

6

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

Bronte G, Rolfo C, Giovannetti E, Cicero G, Pauwels P, Passiglia F, Castiglia M, Rizzo S, Vullo FL, Fiorentino E, Van Meerbeeck J, Russo A. Bronte G, et al. Crit Rev Oncol Hematol. 2014 Feb;89(2):300-13. doi: 10.1016/j.critrevonc.2013.08.003. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24041630

7

Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study).

Van Meerbeeck J, Galdermans D, Bustin F, De Vos L, Lechat I, Abraham I. Van Meerbeeck J, et al. Eur J Cancer Care (Engl). 2014 May;23(3):370-9. doi: 10.1111/ecc.12146. Epub 2013 Oct 24. Eur J Cancer Care (Engl). 2014. PMID: 24152297 Clinical Trial.

8

Zikos E, Ghislain I, Coens C, Ediebah DE, Sloan E, Quinten C, Koller M, van Meerbeeck JP, Flechtner HH, Stupp R, Pallis A, Czimbalmos A, Sprangers MA, Bottomley A. Zikos E, et al. Among authors: van meerbeeck jp. Lancet Oncol. 2014 Feb;15(2):e78-89. doi: 10.1016/S1470-2045(13)70493-5. Lancet Oncol. 2014. PMID: 24480558 Review.

9

Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.

Rolfo C, Fanale D, Hong DS, Tsimberidou AM, Piha-Paul SA, Pauwels P, Van Meerbeeck JP, Caruso S, Bazan V, Cicero G, Russo A, Giovannetti E. Rolfo C, et al. Among authors: van meerbeeck jp. Curr Pharm Biotechnol. 2014;15(5):475-85. doi: 10.2174/1389201015666140519123219. Curr Pharm Biotechnol. 2014. PMID: 24846062 Review.

10

Novel treatment options in stage I non-small-cell lung cancer.

Tarasevych S, Lauwers P, Vandaele F, van Meerbeeck JP. Tarasevych S, et al. Among authors: van meerbeeck jp. Expert Rev Anticancer Ther. 2014 Sep;14(9):1007-20. doi: 10.1586/14737140.2014.929500. Epub 2014 Jun 14. Expert Rev Anticancer Ther. 2014. PMID: 24930519 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

334 results

Search Page